I am a few weeks post-retirement. Having written thank you notes and completed urgent home projects, I swing in a hammock at our currently fire-threatened cabin north of Winthrop, Wash., and reflect. I feel like a young boy while freely flipping pages of a hand-scribed picture book, The Principles of Uncertainty, by Maira Kalman. She…
Search results for: knee osteoarthritis
EULAR 2015: Benefits of Individualizing Exercise Therapy
ROME, Italy—The medical environment is increasingly adapting to the possibilities of optimizing care by individualizing medical treatment and tailoring treatment to disease phenotypes. Data suggest that individualizing exercise therapy, an important treatment modality for rheumatic and musculoskeletal diseases, can help control disease, maximize function, minimize functional barriers and decrease the risk of co-morbidity.1,2,3 Personalizing exercise…
Ankle Replacement: Are Patients with Ankle Arthritis Good Candidates?
Ankle arthritis is a debilitating condition that leaves many patients in severe pain and greatly limits their activities. Until recently, the standard treatment for bone-on-bone ankle pain has been ankle fusion, or arthrodesis, in which surgeons literally fuse the bones of the ankle joint together. However, in the past few years, total ankle replacement surgery,…
Vitamin C Derivative Promising Option for OA
New research in mice has found that treatment with a vitamin C derivative can effectively suppress the generation of mitochondrial superoxide, which plays a role in cartilage degeneration and the progression of osteoarthritis…
FDA Issues Safety Alerts for Bisphosphonates & SGLT2 Inhibitors
Safety The Food and Drug Administration (FDA) has updated the Warnings and Precautions sections of prescribing information for the bisphosphonate agents, including risedronate sodium tablets and combinations with calcium (Actonel/Atelvia), alendronate and combinations with vitamin D (Binosto/Fosamax), ibandronate (Boniva), etidronate (Didronel) and the RANK-ligand inhibitor denosumab (Prolia/Xgeva).1 This information relates to an increased risk for…
Patient’s Journey with Rheumatoid Arthritis Redefines ‘Treat to Target’
Rheumatologist Richard Brasington, MD, says patient John Reigstad’s active participation in treatment decisions shows how much improving quality of life matters
2014 ACR/ARHP Annual Meeting: Alive and Growing
Bone disorders play role in development of osteoarthritis pain, progression
The Rheumatologist as Detective
A case of difficult-to-diagnose Whipple’s disease
Osteoimmunology Research May Benefit Patients with Rheumatoid Arthritis
Cross-talk between bone biology, immune system may shed light on joint erosion, refine therapeutic targets for RA
10 Tips for Opioid Prescribing
How to manage the risks when prescribing medications for patients in chronic pain
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 43
- Next Page »